Albert Bourla is the founder of Pfizer. He became CEO in January 2019 and has focused on transforming Pfizer into a science-driven company.
Albert Bourla is the Chairman and Chief Executive Officer of Pfizer, a global biopharmaceutical company that discovers, develops, manufactures, markets, sells, and distributes biopharmaceutical products. He became CEO in January 2019 and has focused on transforming Pfizer into a science-driven company, increasing investment in R&D and technology. Under his leadership, Pfizer has made significant acquisitions, including Seagen in 2023 and Metsera in 2025, to advance its pipeline in oncology, internal medicine, inflammation and immunology, vaccines, and obesity and metabolic disease. He is also recognized for leading Pfizer's rapid development of a COVID-19 vaccine and antiviral treatment.
Full founder directory · Investor directory · Company funding database · Fundraising library